node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
FOXA1 | PDX1 | ENSAPLP00000020851 | ENSAPLP00000019619 | Forkhead box A1. | Homeobox domain-containing protein. | 0.444 |
HNF1A | INS | ENSAPLP00000002032 | ENSAPLP00000012854 | Homeobox domain-containing protein. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.403 |
HNF1A | PAX4 | ENSAPLP00000002032 | ENSAPLP00000030875 | Homeobox domain-containing protein. | Paired box 4. | 0.492 |
HNF1A | PDX1 | ENSAPLP00000002032 | ENSAPLP00000019619 | Homeobox domain-containing protein. | Homeobox domain-containing protein. | 0.460 |
HNF1A | PTF1A | ENSAPLP00000002032 | ENSAPLP00000021312 | Homeobox domain-containing protein. | Pancreas associated transcription factor 1a. | 0.457 |
INS | HNF1A | ENSAPLP00000012854 | ENSAPLP00000002032 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Homeobox domain-containing protein. | 0.403 |
INS | IRS2 | ENSAPLP00000012854 | ENSAPLP00000027984 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2. | 0.587 |
INS | IRS4 | ENSAPLP00000012854 | ENSAPLP00000000739 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 4. | 0.971 |
INS | PAX4 | ENSAPLP00000012854 | ENSAPLP00000030875 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Paired box 4. | 0.527 |
INS | PAX6 | ENSAPLP00000012854 | ENSAPLP00000004507 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Paired box 6. | 0.735 |
INS | PDX1 | ENSAPLP00000012854 | ENSAPLP00000019619 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Homeobox domain-containing protein. | 0.654 |
INS | PTF1A | ENSAPLP00000012854 | ENSAPLP00000021312 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Pancreas associated transcription factor 1a. | 0.620 |
IRS2 | INS | ENSAPLP00000027984 | ENSAPLP00000012854 | Insulin receptor substrate 2. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.587 |
IRS2 | PDX1 | ENSAPLP00000027984 | ENSAPLP00000019619 | Insulin receptor substrate 2. | Homeobox domain-containing protein. | 0.453 |
IRS4 | INS | ENSAPLP00000000739 | ENSAPLP00000012854 | Insulin receptor substrate 4. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.971 |
IRS4 | PDX1 | ENSAPLP00000000739 | ENSAPLP00000019619 | Insulin receptor substrate 4. | Homeobox domain-containing protein. | 0.453 |
PAX4 | HNF1A | ENSAPLP00000030875 | ENSAPLP00000002032 | Paired box 4. | Homeobox domain-containing protein. | 0.492 |
PAX4 | INS | ENSAPLP00000030875 | ENSAPLP00000012854 | Paired box 4. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.527 |
PAX4 | PDX1 | ENSAPLP00000030875 | ENSAPLP00000019619 | Paired box 4. | Homeobox domain-containing protein. | 0.470 |
PAX6 | INS | ENSAPLP00000004507 | ENSAPLP00000012854 | Paired box 6. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.735 |